Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 102Terminated 17Unknown 15Withdrawn 5Active not recruiting 5Recruiting 2Not yet recruiting 1No longer available 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Hematologic Neoplasms 2Recurrence 1Older Patients 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia 1Graft vs Host Disease 1

Interventions

venetoclax 4Cyclophosphamide 4fludarabine 3Azacitidine 3blinatumomab 2Whole-Body Irradiation 2Cytarabine 2Blood Specimen Collection 2pegaspargase 1etoposide phosphate 1capivasertib 1Vincristine 1Tretinoin 1Tissue Banks 1Tacrolimus 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Immunotherapy, Adoptive 1IPI-549 1Etoposide 1Drug Therapy, Combination 1Doxorubicin 1Dexamethasone 1Decitabine 1Calcium Dobesilate 1Busulfan 1Arsenic Trioxide 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia × Busulfan × Clear all
NCT07524530 2026-05-27

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Not yet recruiting
98 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡